Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Biocon Limited
Press Release Feb 04 2021
Published Feb 4 2021
4 min read

Press Release Feb 04 2021

Biocon Limited has informed the Exchange regarding a press release dated February 04, 2021, titled "Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries, Will enable access to Trastuzumab & Pegfilgrastim in Africa & Asia".

View Attachment